![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: CADPS |
Gene summary for CADPS |
![]() |
Gene information | Species | Human | Gene symbol | CADPS | Gene ID | 8618 |
Gene name | calcium dependent secretion activator | |
Gene Alias | CADPS1 | |
Cytomap | 3p14.2 | |
Gene Type | protein-coding | GO ID | GO:0001505 | UniProtAcc | Q9ULU8 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
8618 | CADPS | HTA11_3410_2000001011 | Human | Colorectum | AD | 3.40e-12 | 4.17e-01 | 0.0155 |
8618 | CADPS | HTA11_2951_2000001011 | Human | Colorectum | AD | 2.55e-06 | 7.51e-01 | 0.0216 |
8618 | CADPS | HTA11_1938_2000001011 | Human | Colorectum | AD | 1.39e-47 | 1.70e+00 | -0.0811 |
8618 | CADPS | HTA11_78_2000001011 | Human | Colorectum | AD | 4.90e-30 | 1.29e+00 | -0.1088 |
8618 | CADPS | HTA11_3361_2000001011 | Human | Colorectum | AD | 2.28e-06 | 4.84e-01 | -0.1207 |
8618 | CADPS | HTA11_696_2000001011 | Human | Colorectum | AD | 9.47e-21 | 7.07e-01 | -0.1464 |
8618 | CADPS | HTA11_866_2000001011 | Human | Colorectum | AD | 1.65e-15 | 6.05e-01 | -0.1001 |
8618 | CADPS | HTA11_1391_2000001011 | Human | Colorectum | AD | 5.70e-42 | 1.71e+00 | -0.059 |
8618 | CADPS | HTA11_866_3004761011 | Human | Colorectum | AD | 6.06e-07 | 3.08e-01 | 0.096 |
8618 | CADPS | HTA11_10711_2000001011 | Human | Colorectum | AD | 8.95e-11 | 5.54e-01 | 0.0338 |
8618 | CADPS | HTA11_7696_3000711011 | Human | Colorectum | AD | 7.11e-16 | 4.85e-01 | 0.0674 |
8618 | CADPS | HTA11_6818_2000001011 | Human | Colorectum | AD | 5.17e-04 | 4.92e-01 | 0.0112 |
8618 | CADPS | HTA11_6818_2000001021 | Human | Colorectum | AD | 4.00e-22 | 9.66e-01 | 0.0588 |
8618 | CADPS | HTA11_99999971662_82457 | Human | Colorectum | MSS | 2.20e-13 | 4.89e-01 | 0.3859 |
8618 | CADPS | HTA11_99999973899_84307 | Human | Colorectum | MSS | 9.55e-14 | 6.63e-01 | 0.2585 |
8618 | CADPS | F007 | Human | Colorectum | FAP | 1.47e-18 | 9.10e-01 | 0.1176 |
8618 | CADPS | A002-C-010 | Human | Colorectum | FAP | 2.31e-20 | 6.60e-01 | 0.242 |
8618 | CADPS | A001-C-207 | Human | Colorectum | FAP | 5.37e-13 | 6.89e-01 | 0.1278 |
8618 | CADPS | A015-C-204 | Human | Colorectum | FAP | 1.15e-04 | 4.61e-01 | -0.0228 |
8618 | CADPS | A002-C-201 | Human | Colorectum | FAP | 3.62e-16 | 7.15e-01 | 0.0324 |
Page: 1 2 3 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:00171574 | Cervix | CC | regulation of exocytosis | 39/2311 | 202/18723 | 2.90e-03 | 1.93e-02 | 39 |
GO:00068873 | Cervix | CC | exocytosis | 59/2311 | 352/18723 | 8.74e-03 | 4.48e-02 | 59 |
GO:0045921 | Colorectum | AD | positive regulation of exocytosis | 33/3918 | 86/18723 | 1.58e-04 | 2.20e-03 | 33 |
GO:0051047 | Colorectum | AD | positive regulation of secretion | 90/3918 | 310/18723 | 4.11e-04 | 4.66e-03 | 90 |
GO:1903532 | Colorectum | AD | positive regulation of secretion by cell | 82/3918 | 282/18723 | 6.85e-04 | 7.00e-03 | 82 |
GO:0006887 | Colorectum | AD | exocytosis | 96/3918 | 352/18723 | 2.48e-03 | 1.90e-02 | 96 |
GO:0017157 | Colorectum | AD | regulation of exocytosis | 59/3918 | 202/18723 | 3.20e-03 | 2.36e-02 | 59 |
GO:0099003 | Colorectum | AD | vesicle-mediated transport in synapse | 57/3918 | 200/18723 | 6.53e-03 | 4.06e-02 | 57 |
GO:00459211 | Colorectum | SER | positive regulation of exocytosis | 25/2897 | 86/18723 | 9.88e-04 | 1.17e-02 | 25 |
GO:00068871 | Colorectum | SER | exocytosis | 75/2897 | 352/18723 | 2.05e-03 | 2.03e-02 | 75 |
GO:00510471 | Colorectum | SER | positive regulation of secretion | 65/2897 | 310/18723 | 5.71e-03 | 4.19e-02 | 65 |
GO:00171571 | Colorectum | SER | regulation of exocytosis | 45/2897 | 202/18723 | 6.46e-03 | 4.63e-02 | 45 |
GO:19035321 | Colorectum | MSS | positive regulation of secretion by cell | 74/3467 | 282/18723 | 7.93e-04 | 8.36e-03 | 74 |
GO:00510472 | Colorectum | MSS | positive regulation of secretion | 80/3467 | 310/18723 | 8.55e-04 | 8.75e-03 | 80 |
GO:00990031 | Colorectum | MSS | vesicle-mediated transport in synapse | 54/3467 | 200/18723 | 1.94e-03 | 1.67e-02 | 54 |
GO:00459212 | Colorectum | MSS | positive regulation of exocytosis | 27/3467 | 86/18723 | 2.76e-03 | 2.17e-02 | 27 |
GO:0099504 | Colorectum | MSS | synaptic vesicle cycle | 48/3467 | 181/18723 | 4.85e-03 | 3.39e-02 | 48 |
GO:00990032 | Colorectum | FAP | vesicle-mediated transport in synapse | 51/2622 | 200/18723 | 1.09e-05 | 3.08e-04 | 51 |
GO:00995041 | Colorectum | FAP | synaptic vesicle cycle | 45/2622 | 181/18723 | 6.73e-05 | 1.28e-03 | 45 |
GO:0023061 | Colorectum | FAP | signal release | 94/2622 | 463/18723 | 1.06e-04 | 1.76e-03 | 94 |
Page: 1 2 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
CADPS | SNV | Missense_Mutation | novel | c.2033N>T | p.His678Leu | p.H678L | Q9ULU8 | protein_coding | deleterious(0) | benign(0.084) | TCGA-DD-A3A9-01 | Liver | liver hepatocellular carcinoma | Female | <65 | I/II | Unknown | Unknown | PD |
CADPS | SNV | Missense_Mutation | novel | c.2032N>A | p.His678Asn | p.H678N | Q9ULU8 | protein_coding | deleterious(0) | benign(0.104) | TCGA-DD-A3A9-01 | Liver | liver hepatocellular carcinoma | Female | <65 | I/II | Unknown | Unknown | PD |
CADPS | SNV | Missense_Mutation | novel | c.253N>A | p.Gly85Ser | p.G85S | Q9ULU8 | protein_coding | tolerated(1) | benign(0) | TCGA-DD-AACB-01 | Liver | liver hepatocellular carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
CADPS | SNV | Missense_Mutation | novel | c.402N>G | p.Asn134Lys | p.N134K | Q9ULU8 | protein_coding | deleterious(0.02) | probably_damaging(0.986) | TCGA-DD-AACC-01 | Liver | liver hepatocellular carcinoma | Male | <65 | I/II | Unknown | Unknown | PD |
CADPS | SNV | Missense_Mutation | c.280N>G | p.Pro94Ala | p.P94A | Q9ULU8 | protein_coding | deleterious(0.05) | probably_damaging(0.956) | TCGA-DD-AADL-01 | Liver | liver hepatocellular carcinoma | Male | <65 | I/II | Unknown | Unknown | SD | |
CADPS | SNV | Missense_Mutation | c.1295N>G | p.Gln432Arg | p.Q432R | Q9ULU8 | protein_coding | tolerated(0.13) | benign(0.272) | TCGA-UB-A7MB-01 | Liver | liver hepatocellular carcinoma | Male | <65 | I/II | Targeted Molecular therapy | sorafenib | PD | |
CADPS | SNV | Missense_Mutation | novel | c.1161C>A | p.Asn387Lys | p.N387K | Q9ULU8 | protein_coding | tolerated(0.93) | probably_damaging(0.986) | TCGA-05-4427-01 | Lung | lung adenocarcinoma | Female | >=65 | I/II | Chemotherapy | cisplatin | CR |
CADPS | SNV | Missense_Mutation | novel | c.3047N>A | p.Pro1016His | p.P1016H | Q9ULU8 | protein_coding | deleterious(0.04) | benign(0.005) | TCGA-38-4631-01 | Lung | lung adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | PD |
CADPS | SNV | Missense_Mutation | novel | c.1835N>T | p.Arg612Leu | p.R612L | Q9ULU8 | protein_coding | tolerated(0.08) | probably_damaging(0.992) | TCGA-38-4631-01 | Lung | lung adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | PD |
CADPS | SNV | Missense_Mutation | c.755N>C | p.Arg252Pro | p.R252P | Q9ULU8 | protein_coding | tolerated(0.09) | possibly_damaging(0.511) | TCGA-38-4632-01 | Lung | lung adenocarcinoma | Male | <65 | III/IV | Chemotherapy | gemcitabine | PD |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |